CIK 0001262104 · Non-accelerated filer<br>Smaller reporting company
Lite Strategy, Inc.
Sign in to watch- Ticker
- LITS
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510407811
- Phone
- 858-369-7100
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- MEI Pharma, Inc., MARSHALL EDWARDS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-06 | Urso David M Chief Operating Officer & GC | Shares withheld for taxes | −17,764 | $3.75 | $67K | 33,606 |
| 2018-08-06 | Mass Robert D. Chief Medical Officer | Shares withheld for taxes | −17,709 | $3.75 | $66K | 33,661 |
| 2018-08-06 | GOLD DANIEL P PHD Chief Executive Officer | Shares withheld for taxes | −54,093 | $3.75 | $203K | 319,727 |
| 2018-07-12 | Urso David M Chief Operating Officer & GC | Grant or award · Stock Option (Right to Buy) | +220,000 | 220,000 | ||
| 2018-07-12 | Mass Robert D. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2018-07-12 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2018-07-12 | Drazba Brian G. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-07-12 | White Christine Anna Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-07-12 | Rueckert William Dodge Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-07-12 | Reynolds Thomas C Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-07-12 | Glover Nicholas Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-07-12 | DRISCOLL FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-07-12 | Clemens Kevan Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-07-12 | Baltic Charles V. III Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-06-22 | Drazba Brian G. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2018-06-22 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +380,000 | 380,000 | ||
| 2018-06-22 | Mass Robert D. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-06-22 | Urso David M Sr. V.P. and General Counsel | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2018-03-29 | GOLD DANIEL P PHD Chief Executive Officer | Shares withheld for taxes | −128,920 | $2.07 | $267K | 271,080 |
| 2018-02-22 | DRISCOLL FREDERICK W Director | Grant or award · Options to purchase shares of common stock | +33,333 | 33,333 |
Page 8 of 13 · 252 trades